Medical/Pharmaceuticals
GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023
Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...
2023-11-20 14:39
1164
Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023
The company will be presenting its growing pipeline of superb technologies for treating all four heart valves in its booth and at multiple events during the conference. HANGZHOU, China, Nov. 20, 2023 /PRNewswire/ -- Venus Medtech is changing how the world treats structural heart disease. The com...
2023-11-20 07:09
1557
Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.
SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...
2023-11-18 08:00
2796
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
Conference call webcast is scheduled for November 22 at 9 a.m. ET.
SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited
2023-11-17 22:21
3551
Oncoclínicas has Net Profit of R$149 million (162% higher vs 3Q22) and Gross Revenue of R$1.5 billion in the third quarter
Operating Cash Generation was R$322 million, a record for the company's third quarter SÃO PAULO, Nov. 17, 2023 /PRNewswire/ -- Oncoclínicas & Co. (B3: ONCO3) reported a 23.4% increase in its gross revenue in the third quarter of 2023, reachingR$1.5 billion, another record for the company. The pe...
2023-11-17 22:10
1992
The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS
The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Institute of Human Gene...
2023-11-17 21:02
1409
Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform
YANGZHOU, China, Nov. 17, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today the upcoming la...
2023-11-17 21:00
1217
Taiwan Lubricate for academic research and health products development
TAICHUNG, Nov. 17, 2023 /PRNewswire/ -- Based in Taiwan, T-BAL is the leading service provider in measurements of lipids and metabolites for both academics and industry. In the collaboration with Lipotype GmbH,Germany (the world leader in lipidomics profiling service), T-BAL has developed advance...
2023-11-17 20:00
1094
Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference
Using single cell multi-omics analysis to predict treatment outcome, develop
disease prognostics and track patient responses to CAR T therapies
COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies
2023-11-17 17:58
1137
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement
SAGAMIHARA, Japan, Nov. 17, 2023 /PRNewswire/ -- epitoMAP Inc. (hereinafter "epitoMAP") and Animal Allergy Clinical Laboratories Inc. (hereinafter "AACL") entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. (hereinafter...
2023-11-17 16:00
1142
Fosun International Wins "Best in ESG Practices" and "Best in ESG Report" at TVB ESG Awards 2023
HONG KONG, Nov. 17, 2023 /PRNewswire/ -- On 9 November 2023, the TVB ESG Awards 2023 (the "Awards"), organized by Television Broadcasts Limited ("TVB") was held at the Hong Kong Convention and Exhibition Center. Fosun International was honored with "Best in ESG Practices" and "Best in ESG Report"...
2023-11-17 15:23
2883
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ("CRDMO") focused on antibody drug conjugates ("ADC") and the broader bioconjugate market, listed on the...
2023-11-17 14:00
2544
Over 86 percent of Thai and Indonesian Women Consider Thalassemia Screening after Learning about Associated Health Risks
Thai (91.2%) and Indonesian (86.6%) women consider screening after learning
about health risks and costs which is higher than the global average of 84.5%
BANGKOK, Nov. 17, 2023 /PRNewswire/ -- According to Thailand's Ministry of
Public Health
2023-11-17 08:22
1724
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day
* Clinical programs, including ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and ATG-037 (oral CD73 inhibitor) have shown clinical responses in cancer patients with advanced diseases. * ATG-008 (dual mTORC1/2 inhibitor) continued showing strong cli...
2023-11-17 08:00
1825
Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals
- Lunit brings Lunit INSIGHT CXR to five major Saudi hospitals, aiming to enhance early detection of common lung abnormalities and improve patient outcomes in line with the national health strategy SEOUL, South Korea, Nov. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of ...
2023-11-16 22:00
1342
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years. In the trial, ...
2023-11-16 22:00
1231
Heuron to Participate in RSNA 2023, Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke
SEOUL, South Korea, Nov. 16, 2023 /PRNewswire/ -- Heuron, a medical AI (artificial intelligence) imaging software solution company, under the leadership of CEO Dr.Donghoon Shin, is scheduled to take part in the 2023 Radiological Society ofNorth America (RSNA) conference, scheduled for this month...
2023-11-16 21:00
1319
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug
Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that will be tested as part of Phase 2 trial The first participant has been dosed in this partially double-blind study to evaluate the safety and efficacy of what has the po...
2023-11-16 20:20
1234
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing
NEWARK, Del., Nov. 16, 2023 /PRNewswire/ -- ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, recently announces the launch of GMP grade DLL4. GMP grade DLL4 is a recombinant, soluble form of Delta-like Ligand 4, or DLL4, ...
2023-11-16 20:08
1141
CU Medicine develops novel microbiome technology MOZAICTM for faecal microbiota transplantation
Enhancing treatment success for Clostridioides difficile infections to over 90% HONG KONG, Nov. 16, 2023 /PRNewswire/ -- Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up to 35% and 40%, respectiv...
2023-11-16 17:26
1449
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
6378
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4460
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4054
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
3188
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
3117